Core Viewpoint - Rosen Law Firm is urging investors of Lantheus Holdings, Inc. to secure legal counsel before the November 10, 2025 deadline for a securities class action lawsuit related to the company's performance during the specified class period [1][3]. Group 1: Class Action Details - Investors who purchased Lantheus securities between February 26, 2025, and August 5, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must act by the November 10, 2025 deadline to serve as lead plaintiff [3][5]. - The lawsuit alleges that Lantheus provided misleading statements about its product Pylarify, failing to disclose critical information regarding its competitive position and pricing strategy, which ultimately harmed investors when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering hundreds of millions for investors [4]. - The firm has been recognized for its leadership in securities class action settlements, achieving significant recoveries, including over $438 million in 2019 alone [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Freeport-McMoRan Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Legal Action and Investor Rights - Shareholders who purchased Freeport securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees, facilitated by a contingency fee arrangement [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to Freeport [2]. Group 2: Incident Impact - On September 24, 2025, Freeport released an update regarding a mud rush incident at the Grasberg Block Cave mine in Indonesia, which resulted in the fatal injuries of two team members [3]. - Following the announcement of this incident, Freeport's stock experienced a significant decline of 16.95% on the same day [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in this area [4]. - The firm has achieved notable settlements, including the largest securities class action settlement against a Chinese company and has consistently ranked highly in securities class action settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering substantial amounts for its clients [4].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers and acquirers of Synopsys, Inc. securities for the period between December 4, 2024, and September 9, 2025, due to alleged misleading statements and failure to disclose material adverse facts about the company's business and operations [1][5]. Group 1: Lawsuit Details - The lawsuit claims that during the Class Period, Synopsys made materially false and misleading statements regarding its business focus on artificial intelligence customers, which negatively impacted its Design IP business economics [5]. - Defendants allegedly failed to disclose that certain decisions regarding road maps and resources were unlikely to yield intended results, leading to a material negative impact on financial results [5]. - The lawsuit asserts that the positive statements made by the defendants about Synopsys' business lacked a reasonable basis and were materially misleading [5]. Group 2: Participation Information - Investors who purchased Synopsys securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. - A lead plaintiff must move the Court by December 30, 2025, to represent other class members in directing the litigation [1][3].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of Nidec Corporation shareholders due to allegations of materially misleading business information issued by the company [2][3]. Group 1: Investigation Details - The investigation is prompted by a significant drop in Nidec's stock price, which fell 22% following a report of accounting issues related to its management [4]. - Nidec's American Depositary Receipts (ADRs) experienced a 22.7% decline on September 4, 2025, marking the largest one-day drop for the company [4]. Group 2: Class Action Information - Investors who purchased Nidec Corporation securities may be eligible for compensation through a class action lawsuit without any upfront costs, as the Rosen Law Firm operates on a contingency fee basis [3]. - Interested investors can join the prospective class action by submitting a form or contacting the firm directly [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company and consistently ranking among the top firms for securities class action settlements since 2013 [5]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [5].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Agilon Health, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation Details - The investigation is prompted by claims that Agilon Health may have provided misleading information to investors [1]. - Shareholders who purchased Agilon Health securities may be entitled to compensation through a class action without any out-of-pocket fees [2]. Group 2: Company Performance - On August 4, 2025, Agilon Health reported its second-quarter results, indicating that industry headwinds were more severe than previously anticipated [3]. - Following the announcement, Agilon Health's stock experienced a significant decline of 51.5% on August 5, 2025 [3]. Group 3: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions [4]. - The firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Legal Action and Investor Rights - Shareholders who purchased Tandem Diabetes Care securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to the misleading information [2]. Group 2: Company Incident and Stock Impact - On August 7, 2025, Tandem Diabetes Care announced a voluntary medical device correction for select t:slim X2 insulin pumps due to a potential speaker-related issue that could lead to insulin delivery discontinuation [3]. - Following this announcement, Tandem Diabetes' stock experienced a significant decline of 19.9% on the same day [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - A class action lawsuit has been filed against Synopsys, Inc. for allegedly making materially false and misleading statements regarding its business operations and financial prospects during the specified Class Period from December 4, 2024, to September 9, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Synopsys failed to disclose significant adverse facts about its business, particularly regarding its focus on artificial intelligence customers, which negatively impacted its Design IP business [5]. - Defendants allegedly made positive statements about Synopsys' business that were misleading and lacked a reasonable basis, leading to investor damages when the truth was revealed [5]. Group 2: Investor Information - Investors who purchased Synopsys securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [4]. - The firm has recovered hundreds of millions of dollars for investors, with notable achievements in previous years, including over $438 million secured in 2019 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Lantheus Holdings, Inc. during the specified Class Period of the upcoming lead plaintiff deadline on November 10, 2025 [1]. Group 1: Class Action Details - Investors who purchased Lantheus securities between February 26, 2025, and August 5, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by November 10, 2025 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [4]. Group 3: Case Allegations - The lawsuit alleges that Lantheus provided misleading statements regarding the competitive position of its product, Pylarify, while failing to disclose critical information about pricing and market dynamics [5]. - It is claimed that Lantheus's early 2025 price increase, despite previous price erosion, created opportunities for competitive pricing that jeopardized Pylarify's market position and revenue potential [5].

Core Points - Rosen Law Firm is reminding investors of Lantheus Holdings, Inc. about the November 10, 2025 deadline to join a securities class action lawsuit related to the company's stock performance during the Class Period from February 26, 2025, to August 5, 2025 [1][2]. Group 1: Class Action Details - Investors who purchased Lantheus securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by November 10, 2025 [3]. - The lawsuit alleges that Lantheus provided misleading statements about its product Pylarify, failing to disclose critical information regarding its competitive position and pricing strategy [5]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of successful settlements in securities class actions, including a notable settlement against a Chinese company and has recovered hundreds of millions for investors [4]. Group 3: Case Background - The lawsuit claims that Lantheus made overwhelmingly positive statements while concealing material adverse facts about Pylarify's market position, which led to investor damages when the truth was revealed [5].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of CarMax, Inc. investors for securities purchased between June 20, 2025, and November 5, 2025, due to alleged misleading statements regarding the company's growth prospects [2][6]. Group 1: Lawsuit Details - The class action lawsuit claims that CarMax's defendants made materially false and misleading statements about the company's growth, overstating its prospects based on temporary benefits from customer behavior influenced by tariff speculation [6]. - Investors who purchased CarMax securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. Group 2: Next Steps for Investors - Investors interested in joining the CarMax class action can do so by visiting the provided link or contacting the law firm directly, with a deadline to serve as lead plaintiff by January 2, 2026 [4][7]. - It is noted that no class has been certified yet, and investors are encouraged to select qualified counsel with a proven track record in securities class actions [5][8]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong reputation in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [5]. - The firm has consistently ranked highly in terms of the number of securities class action settlements and has recovered hundreds of millions of dollars for investors over the years [5].